Accounts Payable, Current in USD of NKGen Biotech, Inc. from Q1 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
NKGen Biotech, Inc. quarterly Accounts Payable, Current history and change rate from Q1 2021 to Q4 2024.
  • NKGen Biotech, Inc. Accounts Payable, Current for the quarter ending 31 Dec 2024 was $14,391,000.000, a 30.4% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Accounts Payable, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $14,391,000 +$3,351,000 +30.4% 31 Dec 2024 10-K 08 Oct 2025
Q3 2024 $13,451,000 +$5,513,000 +69.5% 30 Sep 2024 10-Q 04 Mar 2025
Q2 2024 $12,694,000 +$12,530,656 +76.7% 30 Jun 2024 10-Q 12 Sep 2024
Q1 2024 $12,835,000 +$12,824,247 +1,192.6% 31 Mar 2024 10-Q 20 May 2024
Q4 2023 $11,040,000 +$10,065,000 +10.3% 31 Dec 2023 10-K 08 Oct 2025
Q3 2023 $7,938,000 +$7,691,074 +31.1% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $163,344 +$32,099 +24.5% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $10,753 -$67,238 -86.2% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $975,000 +$923,193 +17.8% 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 $246,926 +$212,181 +6.1% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $131,245 +$114,023 +6.6% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $77,991 +$59,966 +3.3% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $51,807 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $34,745 30 Sep 2021 10-Q/A 31 Jan 2022
Q2 2021 $17,222 30 Jun 2021 10-Q 16 Aug 2021
Q1 2021 $18,025 31 Mar 2021 10-Q 02 Jul 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.